Internal medicine

Adverse effect

Clinical endpoint

Investigational device exemption

Quality of life (healthcare)

Cervical spine

Range of motion

Nursing

Surgery

Randomized controlled trial

Patient satisfaction

Arthroplasty

Implant failure

Implant

Anterior cervical discectomy and fusion

Clinical trial

Medicine

Journal of Neurosurgery Spine

Food and Drug Administration-approved investigational device exemption (IDE) studies have provided level I evidence supporting cervical disc arthroplasty (CDA) as a safe and effective alternative to anterior cervical discectomy and fusion (ACDF). Long-term CDA outcomes continue to be evaluated. Here, the authors present outcomes at 10 years postoperatively for the single-level CDA arm of an IDE study (postapproval study).

Cervical disc arthroplasty: 10-year outcomes of the Prestige LP cervical disc at a single level